ESMO

Views & Analysis

The Frauenkirche is a church in the Bavarian city of Munich that serves as the cathedral of the Archdiocese of Munich and Freising and seat of its Archbishop.

ESMO round-up: Big win for AstraZeneca in ovarian cancer, an...

Several drugmakers announced significant trial findings at this week’s European Society for Medical Oncology (ESMO) conference in Munich.

News

AstraZeneca's (AZ) Tagrisso (osimertinib)

Tagrisso on target to be EGFR+ lung cancer standard

New phase 3 data presented at ESMO earlier today suggests Tagrisso could be a major step forward in treating patients with EGFR positive non-small cell lung cancer.

News

Rubraca outshines rivals in ovarian cancer maintenance thera...

Clovis' Rubraca, the drug showing significant benefits for all ovarian cancer patients in a maintenance setting – and better results than its rivals.

Views & Analysis

ESMO 2017 preview: AstraZeneca‘s comeback, IO shifts to earl...

A look ahead at some of the most eye-catching data and trends at ESMO 2017

Views & Analysis

Innovations in cancer drug research

While cancer continues to be one of the leading causes of death and illness, new technology and increasing use of real-world data have the potential to revolutionise care.

Partner Content

Partner Content

pharmaphorum and Symplur launch Conference360 Report

pharmaphorum media and Symplur, LLC launch Conference360 Report to help pharma and other stakeholders understand social media conversations around medical congresses

ESMO round-up: Big win for AstraZeneca in ovarian cancer, an...

Tagrisso on target to be EGFR+ lung cancer standard

Rubraca outshines rivals in ovarian cancer maintenance thera...

ESMO 2017 preview: AstraZeneca‘s comeback, IO shifts to earl...

Innovations in cancer drug research

pharmaphorum and Symplur launch Conference360 Report

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

ESMO

Editor's Picks